MD3121F1 - Method of viral hepatitis B prophylaxis - Google Patents

Method of viral hepatitis B prophylaxis

Info

Publication number
MD3121F1
MD3121F1 MDA20050280A MD20050280A MD3121F1 MD 3121 F1 MD3121 F1 MD 3121F1 MD A20050280 A MDA20050280 A MD A20050280A MD 20050280 A MD20050280 A MD 20050280A MD 3121 F1 MD3121 F1 MD 3121F1
Authority
MD
Moldova
Prior art keywords
viral hepatitis
prophylaxis
vaccine
pacovirin
tablets
Prior art date
Application number
MDA20050280A
Other languages
Romanian (ro)
Other versions
MD3121G2 (en
Inventor
Constantin Spinu
Constantin Rimis
Petru IAROVOI
Igor Spanu
Pavel Chintea
Original Assignee
Centrul National Stiintifico-Practic De Medicina Preventiva Al Ministerului Sanatatii Din Republicamoldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrul National Stiintifico-Practic De Medicina Preventiva Al Ministerului Sanatatii Din Republicamoldova filed Critical Centrul National Stiintifico-Practic De Medicina Preventiva Al Ministerului Sanatatii Din Republicamoldova
Priority to MDA20050280A priority Critical patent/MD3121G2/en
Publication of MD3121F1 publication Critical patent/MD3121F1/en
Publication of MD3121G2 publication Critical patent/MD3121G2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention refers to medicine, in particular to the infectious diseases and may be used for viral hepatitis B prophylaxis. Summary of the invention consists in that it is administered the viral hepatitis B vaccine and Pacovirin preparation in tablets, in a dose of 50,0 mg of active substance, during 90 days from the day of administration of the vaccine.
MDA20050280A 2005-09-15 2005-09-15 Method of viral hepatitis B prophylaxis MD3121G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050280A MD3121G2 (en) 2005-09-15 2005-09-15 Method of viral hepatitis B prophylaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050280A MD3121G2 (en) 2005-09-15 2005-09-15 Method of viral hepatitis B prophylaxis

Publications (2)

Publication Number Publication Date
MD3121F1 true MD3121F1 (en) 2006-08-31
MD3121G2 MD3121G2 (en) 2007-03-31

Family

ID=36992845

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050280A MD3121G2 (en) 2005-09-15 2005-09-15 Method of viral hepatitis B prophylaxis

Country Status (1)

Country Link
MD (1) MD3121G2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD223Z (en) * 2010-03-05 2011-02-28 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method for revaccination of children against viral hepatitis B
MD4177C1 (en) * 2011-01-14 2013-02-28 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for vaccination against hepatitis B of persons with immunodeficiency
MD596Z (en) * 2012-10-09 2013-09-30 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for treating chronic viral hepatitis C in children

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD670G2 (en) * 1996-05-08 1997-08-31 Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova Remedy with immunomodulator activity
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B
MD2053C2 (en) * 2001-07-10 2003-07-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Remedy with interferon inducing action
MD2549G2 (en) * 2003-07-18 2005-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the chronic viral hepatitis C

Also Published As

Publication number Publication date
MD3121G2 (en) 2007-03-31

Similar Documents

Publication Publication Date Title
MD4430C1 (en) Compositions and methods for treating hepatitis C virus
MX2012007410A (en) Novel antiviral compounds.
TW200630093A (en) Dose forms
UY30537A1 (en) FLIBANSERIN FORMULATIONS AND METHOD TO MANUFACTURE THEM
EA200701519A1 (en) LIVE ATTENUATED ROTAVIRAL VACCINE FOR ORAL ADMINISTRATION
MY154683A (en) Pharmaceutical composition for a hepatitis c viral protease inhibitor
WO2010116385A3 (en) Pharmaceutical compositions for alleviating unpleasant taste
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
WO2006044968A3 (en) Combination therapy for treating viral infections
EA200800467A1 (en) APPLICATION OF COMPLEX ETHERS OF HYDROXYBENZOIC ACID AND ANALOGUES FOR OBTAINING MEDICINES FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTION
PA8744101A1 (en) METHOD OF COMBINED THERAPY FOR THE TREATMENT OF INFECTION BY THE VIRUS OF HEPATITIS C AND PHARMACEUTICAL COMPOSITIONS FOR USE IN SUCH THERAPY
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
AR045289A1 (en) ORAL DOSAGE FORM OF CONTROLLED RELEASE THAT INCLUDES 4- (2-DI-N-PROPILAMINOETIL) - 2 (3H) -INDOLONE (ROPI-NIROL) AND USE OF SUCH DOSAGE FORM FOR THE PREPARATION OF A MEDICINAL PRODUCT
ES2570401T3 (en) Methods of treatment using single doses of oritavancin
MX2022006742A (en) Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives.
AR048318A1 (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
GT200600263A (en) DOSAGE REGIME FOR PRASUGREL
MX2013003523A (en) Low dose pharmaceutical composition comprising zanamivir.
MD3121G2 (en) Method of viral hepatitis B prophylaxis
MY166524A (en) Therapeutic substance, pharmaceutical composition, helicobacter pylori growth inhibitor and method for conducting anti-helicobacter therapy
MX2017005163A (en) Onapristone extended-release compositions and methods.
TW200618807A (en) Prevention and therapeutical agent for hepatitis C virus infection
MD20060037A (en) Method of treating the acute viral hepatitis C
RU2013120345A (en) NEW METHODS FOR TREATING INFECTIONS CAUSED BY HEPATITIS C VIRUS
JP2020536098A5 (en)

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees